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PHYLOGENY-BASED TUMOR SUBCLONE
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ALLOCATION MODEL
By Li Zeng, Joshua L. Warren and Hongyu Zhao
Yale University
Tumor cells acquire different genetic alterations during the course
of evolution in cancer patients. As a result of competition and selec-
tion, only a few subgroups of cells with distinct genotypes survive.
These subgroups of cells are often referred to as subclones. In recent
years, many statistical and computational methods have been devel-
oped to identify tumor subclones, leading to biologically significant
discoveries and shedding light on tumor progression, metastasis, drug
resistance and other processes. However, most existing methods are
either not able to infer the phylogenetic structure among subclones,
or not able to incorporate copy number variations (CNV). In this
article, we propose SIFA (tumor Subclone Identification by Feature
Allocation), a Bayesian model which takes into account both CNV
and tumor phylogeny structure to infer tumor subclones. We compare
the performance of SIFA with two other commonly used methods us-
ing simulation studies with varying sequencing depth, evolutionary
tree size, and tree complexity. SIFA consistently yields better results
in terms of Rand Index and cellularity estimation accuracy. The use-
fulness of SIFA is also demonstrated through its application to whole
genome sequencing (WGS) samples from four patients in a breast
cancer study.
1. Introduction. During cancer evolution in a patient, cancer cells
acquire different genetic alterations, including single nucleotide variations
(SNV1), copy number variations (CNV), and other more complex changes.
Tumor micro-environment and treatments received by cancer patients pose
selection pressure on tumor cells. As a consequence, tumor cells undergo
Darwinian-like evolution, and only a few subgroups that possess better fit-
ness survive (Nowell, 1976; Greaves and Maley, 2012; Gerlinger et al., 2012;
Burrell et al., 2013). Each of these subgroups is called a subclone and has a
unique genetic alteration profile. Numerous studies in different cancer types
have shown that tumor subclone expansion is associated with metastasis
(Ruiz et al., 2011; Yachida et al., 2010; Gerlinger et al., 2014) and drug
Keywords and phrases: intra-tumor heterogeneity, latent feature allocation, model se-
lection, tumor evolution
1We use SNV and mutation interchangeably in the article.
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treatment (Kreso et al., 2013; Wang et al., 2016; Ojamies et al., 2016). Iden-
tification of subclones’ genotypes and reconstruction of their evolution paths
can help identify possible cancer driver mutations, and bring significant in-
sights into individualized cancer treatment (Aparicio and Caldas, 2013).
Some of the most crucial questions in the study of subclone evolution
are: 1) How many subclones exist in a tumor tissue, and what are their
genotypes? 2) What is the prevalence of each subclone? and 3) What is the
phylogenetic structure among subclones? In recent years, researchers have
devoted great efforts to answer these questions using a variety of techniques,
including whole genome sequencing (WGS) (Schuh et al., 2012; Yates et al.,
2015), whole exome sequencing (WES) (Carter et al., 2012), and targeted
deep sequencing (Schuh et al., 2012; Campbell et al., 2008).
Figure 1 illustrates how tumor subclone information is conveyed in se-
quence data. The left panel in the figure displays a tumor evolutionary tree
with four subclones, where the green node (S1) represents normal cells and
the others are cancerous subclones. We focus on three mutation loci A,B
and C. They start with normal allele status in S1 (two copies of normal
alleles). In subclone S2, the tumor cells gain one copy of mutated allele at
loci A and B. Then S2 subsequently branches to form two more subclones:
S3 where locus B loses one normal copy, and S4 where locus C gains one
mutated copy. Suppose we have four sequencing samples from this tumor,
each being a mixture of the four subclones following mixing coefficients F in
the middle panel. From the sequence data, we can calculate the variant al-
lele frequency (VAF) of A,B,C in each sample as shown in the right panel.
The VAF for a mutation is defined as the percentage of alleles with that
mutation. Note how the phylogenetic structure and subclone genotypes af-
fect the shape of the VAF figure: mutation C emerges later than A,B and
thus has smaller cellularity (the percentage of cells in the sequenced tumor
tissue that harbor the mutation), resulting in a VAF line that lies below A’s
and B’s; although mutations A and B emerge at the same time, B later
undergoes a copy loss in S3, which leads to significantly higher VAF than
A in samples where S3 takes a large fraction. With appropriate statistical
modeling and inference, we can utilize the rich information hidden in tumor
sequence data to study intra-tumor heterogeneity.
1.1. Subclone inference methods. Many popular computational tools have
been developed to extract information from tumor sequence data and deci-
pher genetic profiles for each tumor subclone.
SciClone (Miller et al., 2014) and PyClone (Roth et al., 2014) are among
the earliest efforts in subclone analysis. They both identify subclones by
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=⇒
SNV matrix:
Z =

S1 S2 S3 S4
A 0 1 1 1
B 0 1 1 1
C 0 0 0 1

CNV matrix:
L =

S1 S2 S3 S4
A 2 2 2 2
B 2 2 1 2
C 2 2 2 2

Subclone fractions:
F =

Samples 1 2 3 4
S1 0.8 0.6 0.2 0.2
S2 0.1 0.2 0.2 0.1
S3 0.1 0.1 0.5 0.4
S4 0 0.1 0.1 0.3

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F
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B
C
Variant allele frequency
Fig 1: Overview of how sequence data inform tumor heterogeneity. The left
panel displays a tumor evolutionary tree with four subclones, where the
green node represents normal cells and the pink nodes are cancerous sub-
clones. The letters A,B and C are mutation loci. The bars under each letter
represent alleles, and the bars with red stars are mutated. The middle panel
shows matrix representations of SNV and CNV status of each subclone, and
F represents subclone fractions in each of the four sequencing samples. The
right panel shows the variant allele frequency (VAF) of mutations A,B and
C in each sequencing sample.
grouping SNVs using VAF information and Bayesian clustering models.
Their applications are limited to copy neutral regions, but with allele-specific
copy number information available, they can also be extended to CNV
regions. In addition, SciClone employs a variational Bayesian technique,
which gives it computational advantages in large scale implementation. In-
stead of clustering VAF, Lee et al. (2015) proposed a non-parameteric Bayesian
latent feature allocation model, Bayclone, to directly infer subclone SNV
status. They later extended the model in (Lee et al., 2016) to handle SNVs
in CNV-regions by adding a latent matrix to model CNV status of each
locus.
One major limitation of the above methods is that they fail to incorporate
phylogeny in the inference which may offer insights on the temporal order
of the SNVs’ and CNVs’ emergence. Although it is possible to mannually
recover an evolutionary tree after getting subclone genotypes, such attempts
will likely fail if the inference model does not explicitly enforce a phylogenetic
structure. Several recent methods encompass phylogeny as a key component
in subclone inference (Jiao et al., 2014; Deshwar et al., 2015; Yuan et al.,
2015; Marass et al., 2017; Jiang et al., 2016). Phylosub (Jiao et al., 2014)
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is a non-parametric Bayesian model that infers subclone lineages and frac-
tions using a tree-structured stick-breaking (TSSB) process. However it only
works on copy-neutral genome regions. The later work PhyloWGS (Deshwar
et al., 2015) extends it to CNV-regions when estimates for allele-specific
copy numbers are available. Cloe (Marass et al., 2017) can be viewed as a
tree-guided latent feature allocation model (similar to Bayclone). It samples
posterior phylogenetic trees for each tree size within a pre-specified range,
and uses model selection criterion to choose the best model. Canopy (Jiang
et al., 2016) models tumor progression as a bifurcating tree, where SNVs
and CNVs emerge along the branches and form subclones at leaf nodes.
All of the phylogeny-based methods above either cannot model CNVs, or
require user-provided major and minor allele number estimates, in order to
incorporate copy number information.
In this article, we introduce SIFA (tumor Subclone Identification by Feature
Allocation), an extension of the methods developed by Lee et al. (2016) and
Marass et al. (2017), to model SNV, CNV, and phylogenetic tree under a
unified framework.
2. Model. Subclone identification is essentially a mixture deconvolu-
tion problem. A latent phylogenetic tree and the locations where each SNV
or CNV emerges jointly determine genotypes of subclones. The subclones
form a mixture in tumor tissue and influence what we observe from sequence
data (See Figure 1).
Assume we observe J mutation loci in T WGS samples from the same
patient. For each locus j, let djt denote the number of sequence reads that
cover this locus, and xjt denote the number of reads harboring a mutation
at j. We use D and X as the matrix form representations for the total reads
and mutant reads, respectively. For notation brevity, we use Mi to refer to
the ith column of matrix M , and M(j) to denote the transpose of the jth
row.
We use a latent integer K to denote the number of subclones (normal cells
included) in a tumor tissue. Then the phylogenetic tree can be represented
by a vector T of length K, where Tk = i indicates that the parent of subclone
k is i (if node k is root, Tk = 0). We also fix the root subclone to be normal
cells (i.e. T1 = 0). The phylogenetic tree structure is assumed to be shared
among all sequencing samples from the patient.
For modeling SNVs and CNVs, we make the following assumptions: 1)
Each mutation occurs only once in a specific subclone, and is inherited
by all descendant subclones (a.k.a infinite sites assumption (Jiao et al.,
2014; Kimura, 1969)); and 2) Each CNV occurs at most once in a specific
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subclone, and is also inherited by descendant subclones. We are therefore
able to characterize SNV and CNV status of all loci using J×2 matrices Zo
and Lo, which we call SNV and CNV origin matrix, respectively. For locus
j, Zo(j) = (k, c) indicates that the locus gains c copies of the mutant allele
in subclone k. Similarly, we define Lo(j) = (k, c) to represent a gain (or loss
if c is negative) of c copies of the normal alleles in subclone k. Additionally,
we use J×K matrices Z and L to represent the number of mutant and total
alleles for each locus in each subclone. The middle panel of Figure 1 gives
examples of matrix representations of SNV and CNV status corresponding
to the phylogenetic tree on its left.
WGS data also provide location information of loci. Since CNV occurs in
sections of base pairs, we can harness this information to better infer CNV
status. We sort the loci in the order of chromosomal positions, and divide
the genome into S segments, ∆1,∆2, . . . ,∆S . For any loci i and j in the
same segment, we assume they share the same CNV status (i.e. Lo(i) =
Lo(j)). In our implementation, we use R package copynumber (Nilsen et al.,
2012) to determine genome segments. Details of this method can be found
in Appendix A. Another important latent parameter is the K × T matrix
F, where the tth column Ft characterizes the fractions of each subclone in
sample t.
Our goal is to estimate the parameters Zo,Lo,F, and the evolutionary
tree T , from the observed reads data D and X. We begin by proposing a
probablistic model and a Bayesian sampling algorithm for parameter infer-
ence.
2.1. Likelihood. In this section, we describe the statistical framework of
SIFA. The subclone mixture, if considered as a single subclone, would have
an averaged mutant allele copy number
∑
k zjkfkt = Z
′
(j)Ft, and averaged
total allele copy number
∑
k ljkfkt = L
′
(j)Ft, for locus j in sample t. Thus
the theoretical VAF, which is also the probability for a sequenced read to
be mutant if it covers locus j, can be calculated as the ratio of the two copy
numbers:
(2.1) pjt =
Z′(j)Ft
L′(j)Ft
.
We assume a Binomial distribution for mutant reads xjt conditional on
total reads djt:
(2.2) xjt|djt, pjt ind∼ Binomial(djt, pjt).
6 L. ZENG ET AL.
Moreover, the number of total reads of a locus is known to be positively
correlated with its averaged total copy number in WGS. We therefore use a
Poisson distribution to model djt (Lee et al., 2015; Klambauer et al., 2012)
such that
(2.3) djt|φt,L(j),Ft ind∼ Poisson(φt
L′(j)Ft
2
),
where φt is the designed WGS coverage (or sequencing depth) specified when
conducting sequencing. It is formally defined as the average number of times
each base is sequenced. Notice that when the average total copy number
L′(j)Ft is equal to 2, the distribution has mean and variance equal to φt.
2.2. Prior Specifications.
2.2.1. Clonal fractions. We introduce an additional parameter, θkt, for
each fkt, and denote the matrix of θkt’s as Θ. We assign each θkt an inde-
pendent Gamma(γ, 1) prior distribution, and let
fkt =
θkt∑K
i=1 θkt
.
This is equivalent to assigning Ft a Dirichlet(γ, γ, . . . , γ) prior distribution.
The prior distribution has mean and mode (1/K, 1/K, . . . , 1/K), which gives
no preference to any subclones. The advantage of introducing θkt’s is that we
can sample one Θ element at a time, while sampling fkt requires updating
the entire vector of Ft due to the constraint that the fkt need to sum (over
k) to one. The former approach usually leads to improved mixing using the
Metropolis-Hastings sampling algorithm, thus we work with θkt’s instead of
fkt’s.
2.2.2. SNV and CNV origin matrices. For SNV, we specify a positive
integer MS to be the maximum number of possible mutant copies. We utilize
the following prior for Zo:
p(Zo(j) = (k, c)) ∝ ζc ( 2 ≤ k ≤ K, 1 ≤ c ≤MS).
The above specification makes it equally likely for the SNV to originate
from any subclone (except the normal subclone). Since gaining multiple
copies of mutant alleles is a less likely event, our prior sets the probability
of acquiring c copies of the mutant alleles to be proportional to ζc, where ζ
is a pre-specified value in (0, 1)2.
2We set ζ = 0.01 in our implementations. Sampling results are in general robust against
different choices of ζ if we do not use extremely small values, which pose strong penalty
on multiple mutant copies.
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Likewise, for CNV status, we specify a value MC for the maximum total
allele copies. Let (0, 0) represent the event of no CNV. For each genome
segment ∆s, we specify the prior of its copy number status as
p(Lo(j) = (0, 0) for all j ∈ ∆s) = pi,
and uniform on other possible values. The hyper-parameter pi is given a
Beta(api, bpi) prior.
2.2.3. Phylogenetic tree. We have previously introduced a K-vector rep-
resentation T of the tree structure, where the root node is fixed to be normal
cells. We add one additional constraint: for any 2 ≤ k ≤ K, we require that
Tk ∈ {1, 2, . . . , k−1}. Note that under this constraint T2 can only be 1, which
implies that the second subclone is a direct descendant of normal cells. It
can be shown that any vector T satisfying these constraints is a tree, and
for any tree of size K, we can find a corresponding representation satisfying
the constraints (see Appendix B). We use a discrete uniform distribution on
all possible tree structures as the prior distribution.
Figure 2 presents the parameters’ dependencies in the SIFA model. The
dark grey nodes represent the observed data, while the light grey nodes
represent the latent parameters. Our ultimate goal is to make inference about
Θ,Lo,Zo, and T from the posterior distribution p(Θ,Lo,Zo, T , pi|D,X,Φ),
where Φ = (φ1, φ2, . . . , φT ) represents the read depths of the sequencing
samples.
2.3. Posterior Sampling. For brevity of description, we let Ω denote the
set of all unknown parameters, and Ω−ω denote all unknown parameters
except ω.
We employ Gibbs sampling to acquire posterior samples, and therefore
need to sample from the full conditional distributions for each parameter.
However, since the full conditional distributions for some parameters are in
forms from which direct sampling is difficult, we also employ the Metropolis-
Hastings sampling in such cases.
2.3.1. Subclone fractions. Subclone fractions can be fully represented by
Θ. We update one entry of Θ at a time. Since the full conditional distribution
p(θkt|D,X,Φ,Ω−θkt) cannot be directly sampled, we employ the Metropolis-
Hastings sampling at this step.
Let θkt be the current sample in our Markov chain. A new value θ
∗
kt is
proposed from the transition function h(θ∗kt|θkt, s), where h(·|θkt, s) is the
density function for distribution Gamma(sθkt, s), which is centered at θkt
8 L. ZENG ET AL.
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Fig 2: Illustration of the parameters’ dependency. The dark grey nodes in
the figure stand for the observed data, and the light grey ones represent the
latent parameters.
and has variance θkt/s. The tuning parameter s controls the proposing step-
length, and a larger s value usually leads to a higher acceptance rate. In our
implementation, we adaptively tune its value to keep acceptance rate in a
reasonable range3 in order to ensure efficient mixing of the Markov chain.
2.3.2. SNV, CNV origin matrices. Since the sampling spaces for CNV
status Lo, SNV status Zo are discrete and relatively small, we can perform
Gibbs sampling by calculating the probability for every possible status.
Because loci are independent when sampling SNV status, we update Zo
row by row. For each j, we calculate p(Zo(j) = (k, c)|D,X,Φ,Ω−Zo(j)) for
all possible combinations of (k, c), and use them as weights to sample a new
Zo(j). Sampling of L
o follows a similar procedure, but instead of updating
one locus at a time, one segment of loci is updated together.
We also apply Gibbs sampling to Lo’s hyper-parameter pi, because its full
conditional distribution directly takes the form of a Beta distribution
p(pi|Lo) ∼ Beta(n+ api, S − n+ bpi),
where S is the number of genome segments and n is the number of segments
3We used range [0.4, 0.65] in our implementation.
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without CNV.
2.3.3. Phylogenetic tree. The sample space for the phylogenetic tree T is
discrete as well, including all possible tree structures of size K. The size of
this space is however much larger than Lo’s and Zo’s, and grows fast as K
increases. It is computationally impractical to calculate all possible outcome
probabilities in this case. Instead, we propose a mixed sampling approach,
where we randomly choose to perform the Metropolis-Hastings sampling or
slice sampling (Neal, 2003).
For the Metropolis-Hasting sampling, we employ a simple proposal method:
randomly select a leaf node and rewire it to a randomly selected parent node.
However, this kind of proposal is likely to be rejected, since changes in tree
structure have strong impact on model likelihood. To illustrate this, we cre-
ate a toy example phylogenetic tree with four subclones in the left panel of
Figure 3. The capital letters A,B,C,D are SNVs or CNVs, and the sub-
clones they reside in are their origin subclones. We use the lowercase letters
a, b, c, d to represent subclone fractions. If we change the tree structure by
rewiring node D from its original parent B to a new parent C, then the
cellularity of C increases from c to c + d, while cellularity for B decreases
from b + d to b. If many loci are involved in B and C, the proposal will
lead to dramatic change in the full conditional likelihood. Since the parame-
ters have been sampled in favor of the original tree structure, the change in
likelihood is most likely in the decreasing direction, which will lead to poor
acceptance rate.
A; a
B; b C; c
D; d
=⇒
A; a
B; b+d C; c-c∧d
D; c∧d
original tree proposed tree
Fig 3: Example of the Metropolis-Hastings tree proposal. Node D is the
randomly selected tree leave to be rewired.
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To address this issue, we introduce the following procedure:
1. Randomly select a leaf subclone k (whose current parent is p), and a
valid target parent subclone q. Rewire k to q to get the new tree T ∗.
2. Change the previous parent’s fractions:
θ∗pt = θpt + θkt (t = 1, 2, . . . , T )
3. Change the new parent’s fractions:
θ∗qt = θqt − θkt ∧ θqt (t = 1, 2, . . . , T )
4. Assign new fractions to subclone k:
θ∗kt = θkt ∧ θqt (t = 1, 2, . . . , T )
where x ∧ y stands for the minimum of x and y. Then T ∗ and Θ∗ can be
used to calculate acceptance probability and perform sampling. It can be
shown that, under the condition that θqt ≥ θkt for all t, the proposed tree
has exactly the same likelihood as the original tree. The proof is provided
in Appendix C. Following this sampling strategy, the proposed tree in the
previous example takes the form as displayed in the right panel of Figure
3. Notice that only the cellularity for D is changed, while B and C remain
intact.
Although the above Metropolis-Hastings algorithm is tuned to achieve an
improved acceptance rate, current trees can only change to trees differing
by one subclone. It is possible that the algorithm will be stuck at a locally
optimal tree structure. Therefore, we also include the slice sampling tech-
nique (see Appendix D) as an option in the tree sampling scheme. In each
iteration, we
1. Sample a nuissance parameter u∗ ∼ Uniform(0, p(T |D,X,Φ,Ω−T ))
2. Randomly and repeatedly propose T ∗ from all possible tree structures
and accept the proposal if p(T ∗|D,X,Φ,Ω−T ) ≥ u∗
Slice sampling enables our sampler to make bigger jumps and avoids get-
ting trapped at local modes. In our empirical analysis, a combination of slice
sampling and the Metropolis-Hastings sampling increased our sampler’s mo-
bility, yielded improved sampling performance, and was robust in different
simulation scenarios.
Derivations of the full conditional distributions for all model parameters
are provided in Appendix E.
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2.3.4. Parallel tempering. In MCMC sampling, the technique of parallel
tempering is often adopted to make it easier to jump from one mode to
another (Gelman et al., 2014).
We specify an increasing sequence of temperatures {t1, t2, t3, . . . , tc}, usu-
ally with equally spaced ti = 1 + ∆T (i − 1), where ∆T is the temperature
increment. For each temperature, we specify a corresponding target func-
tion pi(Ω) = p(Ω|D,X,Φ)1/ti . The c target functions share the same set
of modes, however, functions with higher temperature will look more “flat”
which makes it easier for Bayes samplers to explore all modes. We run one
independent chain for each target. At user-specified intervals, we randomly
select a chain i < c and propose to switch chains i and i+ 1. This proposal
is accepted with the following probability (Geyer, 1991):
pi(Ω
(j))pj(Ω
(i))
pi(Ω(i))pj(Ω(j))
,
where Ω(k) is the latest sample from chain k. In the end, samples from chain
1 are taken as posterior samples of p(Ω|D,X,Φ).
2.4. Model selection. After obtaining posterior samples from models with
different numbers of subclones, we need to address the issue of model selec-
tion. Obviously, choosing the model with the maximum likelihood will lead
to overfitting, because models with more subclones are more likely to yield
an improved likelihood. Researchers have utilized a variety of model selection
methods for subclone inference. Marass et al. (2017) used log-posterior like-
lihood of the Maximum a posteriori (MAP) sample as the selection criterion.
However, this approach largely depends on the choice of prior distributions.
If prior distributions are flat, selection by posterior distribution and by max-
imum likelihood are equivalent. Many methods (Jiang et al., 2016; Parisi
et al., 2011; Li and Li, 2014; Zare et al., 2014) adopt the Bayesian informa-
tion criterion (BIC), which adds a penalty term to the negative log-likelihood
in order to penalize complex models. However, there is also concern as how
to calculate the number of free model parameters, since the model involves
both discrete (SNV/CNV status and tree structure) and continuous (sub-
clone fractions) parameters, and they should not contribute equally to model
complexity.
We choose to use a criterion based on Bayes free energy, which is defined
as
F = − log
∫
p(X,D|Ω,Φ)ψ(Ω) dΩ,
where ψ(Ω) is the joint prior density of all parameters. F can be understood
as the negative logarithm of the marginal likelihood of a model. Selecting
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the model with the largest marginal likelihood is equivalent to choosing the
model that minimizes the Bayes free energy. It has been established that,
in regular statistical models, BIC asymptotically approximates F . However,
this is not generally true when the underlying model is singular (e.g. when
posterior distribution have multiple modes) (Watanabe, 2013). A computa-
tional way to evaluate F is
(2.4) Fˆ = −
c∑
j=1
log E
βj+1
Ω [exp(−(βj − βj+1)L(Ω))] ,
where 1 = β1 > β2 > . . . > βc+1 = 0 are the inverse temperatures (i.e.
βj = 1/tj for 1 ≤ j ≤ c), and L(Ω) = − log(X,D|Ω,Φ) is the negative
log-likelihood. The empirical expectation E
βj
Ω is calculated using MCMC
samples from the jth chain(Watanabe, 2013).
3. Simulation. In order to assess the performance of SIFA, we first
generated simulation datasets under different sequencing depths, true sub-
clone numbers, and tree structures, and compared inference results with
Pyclone (Roth et al., 2014), one of the most popular intra-tumor hetero-
geneity analysis methods, and Cloe (Marass et al., 2017), one of the most
recently published methods.
3.1. Simulation setup. We compared the methods in eleven simulation
scenarios in total, including 3× 3 basic simulation scenarios: three values of
sequencing depth = 40, 60, 80 reads per base-pair and three values of true
subclone number K = 3, 4, 5. We used tree structure (0, 1, 1) for K = 3,
(0, 1, 2, 2) for K = 4, and (0, 1, 1, 2, 2) for K = 5. We used the same set of
L and Z matrices for the same K (see Figure 4). The sequencing depths 40
and 60 are commonly adopted in WGS practices, and depth 80 is considered
as high coverage. In all simulations, we fixed the number of loci J = 200,
and the number of sequencing samples T = 4, which also resemble real data
from intra-tumor heterogeneity studies.
In order to study the robustness of the methods against different tree
structure specifications, we considered two other scenarios atK = 5,depth =
40 reads per base-pair. Note that the tree (0, 1, 1, 2, 2) for K = 5 in the basic
scenarios had three leaf nodes. In order to experiment on trees with different
complexities, we further generated two more tree structures: (0, 1, 2, 2, 3)
with two leaf nodes, and (0, 1, 2, 3, 4) with one leaf node. More details about
simulation setup can be found in Appendix F.
3.2. Measure of model performance. We evaluated the performance of
our method using different metrics, including the ability to recover true
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Fig 4: Simulation parameters. The three rows represent simulation param-
eters (including tree structure T , SNV matrix Z, and CNV matrix L) for
K = 3, 4, 5, respectively. The fist column shows the underlying phylogenetic
trees. The second column presents SNV matrices, where the red blocks rep-
resent one mutant copy gain. The third column presents CNV matrices,
where the green blocks represent one copy loss, the red blocks represent one
copy gain, and the black blocks are copy neutral.
phylogenetic trees, the ability to recover the correct number of subclones,
mutation clustering accuracy, and mutation cellularity estimation accuracy.
Since Pyclone does not perform inference for the phylogenetic tree, we only
used the last two criteria to compare SIFA with Pyclone and Cloe.
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The ability to recover true tree structures and subclone numbers can
be assessed by directly comparing model selection results with true T and
K. For mutation clustering accuracy, we used the Rand Index (Rand,
1971), which measures the similarity between two partitions. Clustering is
basically a partitioning of the SNV set A = {SNV1, SNV2, . . . , SNVJ},
into non-overlapping groups. Let P (1) = {P (1)1 , P (1)2 , . . . , P (1)r } and P (2) =
{P (2)1 , P (2)2 , . . . , P (2)s } be two partitions that divide A into r and s groups,
respectively. The Rand Index looks at all pairs of (SNVi, SNVj) and count
how many pairs are assigned to the same group. It is formally defined as:
R(P (1), P (2)) =
TP + TN(J
2
) ,
where
1. TP (true possitive) : pairs of SNVs that are in the same group in P (1)
and also in the same group in P (2)
2. TN (true negative) : pairs of SNVs that are in different groups in P (1)
and also in different groups in P (2).
We calculated this index using posterior partitions acquired from our
MCMC sampler and the true partitions. The Rand Index takes values in
[0, 1], with larger value indicating higher clustering accuracy. The maximum
value of 1 is achieved when the two partitions are exactly the same.
Calculation of cellularity estimation error is straight-forward. Given SNV
and subclone fraction matrix, cellularity of SNVj in sample t is cjt =∑
k∈Γj fkt, where Γj = {k : zjk > 0} is the set of subclones that bear muta-
tion j. Let C be the J × T true cellularity matrix and Cˆ be the cellularity
estimation calculated from a single draw from the posterior distribution.
Cellularity estimation error is defined as the mean of absolute element-wise
difference between C and Cˆ:
Cerr =
∑
j,t |cjt − cˆjt|
JT
.
3.3. Simulation results. When running SIFA, we used the first 2000 it-
erations to tune the adaptive parameter s which controls the step size for
proposals in sampling Θ (see section 2.3.1), 4000 iterations for burn-ins,
and the next 4000 samples for inference. We also ran Pyclone and Cloe for
10,000 iterations and kept the last 4000 samples for inference. When imple-
menting Pyclone, we provided the true minor and major copy numbers for
each locus. Convergence of the MCMC samples was tested using the Geweke
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Fig 5: Comparisons of method performance using the Rand Index and cellu-
larity estimation error (Cerr). The upper panel and lower panel respectively
show results for Rand Index and Cerr in the nine basic simulation scenarios.
Rows represent scenarios with different numbers of underlying subclones,
and columns represent different sequencing depths. Within each scenario,
the three boxes display posterior distributions of the two criteria calculated
using posterior samples from SIFA, Pyclone, and Cloe, respectively.
statistic (Brooks and Gelman, 1998) (see supplementary materials, Figure
29).
SIFA successfully recovered the true phylogenetic structures in all eleven
simulation scenarios. Figure 5 presents the comparison between SIFA, Pyclone
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and Cloe, in terms of Rand Index and Cerr. Results for the two additional
scenarios are shown in Appendix F. Rows in Figure 5 represent scenar-
ios with different numbers of underlying subclones, and columns represent
different sequencing depths. Within each scenario, the three boxes display
the posterior distributions of the two criteria calculated using the posterior
samples from each method. As expected, for each fixed K, all three methods
yielded better performances as simulation sequecing depth increased from
40 to 80. Under scenario K = 5, depth = 40 and tree structure 3, SIFA
did not outperform Pyclone, because one CNV segment was not correctly
identified, leading to incorrect mutation assignments in subclones 2 and 3
(see Figure 4 of the supplementary material and Appendix F). In all other
settings, SIFA had the best results in both Rand Index and cellularity es-
timation. Pyclone also yielded smaller error than Cloe in most cases, but
note that Pyclone took the ground truth minor and major copy number as
input, which gave it certain prior advantages in comparison.
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Fig 6: Point estimates of the SNV matrix Z from the three methods under
scenario K = 5,depth = 60. The first panel represents the gold-standard
Z matrix, and the other three are point estimates from SIFA, Pyclone and
Cloe, respectively.
We also plot the ground truth Z matrix and its point estimates from
the three methods in Figure 6 (take scenario K = 5 and depth = 60 as
example). For SIFA and Cloe, point estimates were calculated using the
posterior median from a selected K. Since Pyclone yielded varying K in
posterior samples, we manually picked the K with the largest posterior fre-
quency, and calculated the median Z matrix using the corresponding subset
of samples. Full details on calculating the posterior point estimates are de-
scribed in Appendix H. From Figure 6, we can see that all three methods
can correctly detect the overall clustering pattern. Pylcone did not perform
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phylogeny inference, thus the subclones have no overlapping SNVs. Cloe
correctly inferred genotypes of four out of five subclones, except subclone 2
whose parent should be the normal subclone.
More detailed results for each simulation are available in Figures 1 - 8 in
the supplementary materials.
4. Application: Breast Cancer. In this section, we apply our method
to a breast cancer dataset (Yates et al., 2015). This study involved 50 breast
cancer patients, where researchers applied WGS and targeted sequencing to
multiple samples from each of the 50 patients’ tumors. We applied SIFA to
patients PD9694, PD9771, PD9777 and PD9849, who have greater or equal
to three WGS samples.
To obtain genome segmentation estimates, we sorted the patients’ loci by
their chromosomal locations, and ran the multipcf segment calling method
using the loci’s total reads information. In WGS, the loci may give false
mutated reads due to technical errors in the sequencing process. In order to
screen out “noise” loci and only keep those that were shared among samples,
we performed a few steps of quality control using criteria including locus
coverage and average VAF across samples (see Appendix G). An overview
of the final input data is presented in Table 1.
Table 1
Overview of the breast cancer dataset
patients number of loci number of segments
PD9694 301 56
PD9771 549 152
PD9777 742 83
PD9849 641 56
We applied SIFA with K = 3, 4, . . . , 7 to the four patients’ sequence data,
and selected the models that minimized Fn. We present the results for pa-
tients PD9694 and PD9777, and leave the others’ results in the supplemen-
tary materials. The SIFA parameters we used for the implementations can
be found in Appendix G.
Patient PD9694 developed multifocal breast cancer. Three WGS samples
were acquired from the patient, with designed sequencing depths 41, 48
and 43, respectively. Two out of three samples (PD9694a and PD9694c)
were from invasive foci, and PD9694d was from an area of DCIS (ductal
carcinoma in situ), which was non-invasive.
Results for PD9694 are presented in the upper row of Figure 7. Our model
selection criterion recommended K = 5 as the best model. The left panel
displays the inferred phylogenetic tree structure and corresponding genes
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for each subclone. The genes presented are among the 184 most mutated
driver genes in breast cancer as reported by the IntOGen-mutation platform
(Gonzalez-Perez et al., 2013). We use different colors to indicate copy number
status: green for copy loss, red for copy gain, and black for copy neutral
genes. Gene SF3B1 is involved in RNA splicing process, and has been found
to be a hotspot mutation gene in breast cancer. Knowing that it originated
from an early phase subclone, we could use targeted therapy for treatment,
such as Spliceostatin A, which is reported to be effective on SF3B1 mutated
cell lines (Maguire et al., 2015). The middle panel presents the composition
of the subclones in each sample. The major components of the DCIS sample
(PD9694d) are subclones 2 and 3, and both were formed in the early stage of
evolution. The two invasive samples each developed a new major subclone
(subclone 5 for PD9694c and subclone 4 for PD9694a). It is possible to
identify gene alterations related to tumor invasiveness from these subclones.
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Fig 7: Breast cancer analysis results for PD9694 (first row) and PD9777
(second row). The left panels present the inferred phylogenetic tree, with
breast cancer related genes listed on its right. Red gene names indicate loci
with copy gain, green names indicate loci with copy loss, and the others
are copy neutral loci. The middle panels show fractions of each subclone
in all WGS samples. Subclones are represented by colors, and the lengths
of each colored segment are proportional to their estimated fractions. The
right panels present the Bayes free energy values calculated in the model
selection step.
The second row of Figure 7 presents the results for a triple negative
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breast cancer patient PD9777. The three WGS samples, PD9777a, PD9777c
and PD9777d, have designed sequencing depths 30, 30 and 57, respectively.
Sample PD9777d was collected from the tumor tissue after neo-adjuvant
chemotherapy, and the other two were from pre-treatment tumor mass.
The fraction plot in the middle panel depicts a contraction of the nor-
mal subclone and an expansion of a cancerous subclone (subclone 3) in the
post-therapy sample, indicating the tumor has developed chemotherapy-
resistance. Gene RB1 might explain the resistance and the expansion of
subclone 3 in PD9777d. It is a negative regulator of the cell cycle and is the
first tumor suppressor gene found. It has also been reported to be associated
with drug sensitivity in triple negative breast cancer (Robinson et al., 2013).
Another interesting finding is that, three out of six driver genes (PIK3R1,
SOS1, SOS2) originated from subclone 2 can be mapped back to the PIK3
pathway, suggesting that this pathway was severely mutated in the early
stage of tumor development. PIK3 is a major intracellular signaling path-
way, and there are rich literatures studying its association with cell growth
and tumor proliferation. This finding provides strong evidence that, the
PIK3 pathway mutations played an important role in the tumor progression
of PD9777.
CNV estimation is generally more reliable for larger segments than smaller
ones. When a segment is short, there is a higher probability that the ob-
served reads of the segment are higher (or lower) than average (the designed
sequencing coverage) just by chance, and subsequently this leads to false
positives in CNV inference. For example, a 3-loci-segment showing below
average reads may happen randomly, but a 50-loci-segment showing below
average reads is a strong indicator of copy loss. To control for false positive
CNV calls, we set the prior distribution of pi (the prior probability of a seg-
ment being copy neutral) close to one, thus a CNV is not assigned unless it
provides considerable increase in model likelihood.
The inferred CNVs of the previous two patients are demonstrated in Fig-
ure 8. The Y-axis shows the log-transformed normalized reads, and seg-
ments without CNVs should contain points centered around zero. The or-
ange points in the figure are loci without estimated CNV, while other colors
indicate CNVs on different chromosomes. From Figure 8, we observe that
most of the segments that have consistent deviations from zero are col-
ored, which manifests the ability of SIFA to successfully capture the major
CNV regions. In patient PD9694, a copy loss was detected in a segment
that covers gene PTEN, a known tumor suppressor gene on chromosome
10. The copy loss took place in subclone five, which is a major component
of sample PD9694c, and can possibly be the cause of the invasiveness of
20 L. ZENG ET AL.
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Fig 8: CNVs detected by SIFA for PD9694 and PD9777. The X-axis rep-
resents mutated loci arranged by their chromosomal locations. The Y-axis
represents the log-transformed loci coverage: the reads for each locus are
divided by median reads and then log-transformed. Loci with no estimated
CNV are indicated with orange points, while points in other colors indicate
CNVs on different chromosomes.
this sample. In PD9849, we detected strong evidence of CNV at a mutated
gene FGFR2 on chromosome 10, whose observed reads were 2-4 times above
average (see Figure 14 of the supplementary materials). It belongs to the
Fibroblast Growth Factor Receptor family, and is found to be a consistent
top hit in genome-wide association studies of breast cancer(Campbell et al.,
2016). SIFA inference suggested that multiple mutant FGFR2 alleles were
acquired at an early stage of the tumor, which could be a cause of tumori-
genesis. More details on the CNV inferences for PD9771 and PD9849 are
presented in Figures 13 - 14 of the supplementary materials.
We also applied Cloe and Pyclone to the dataset, and compared their
inferences with the results from SIFA4. SIFA and Cloe yielded similar overall
SNV clustering patterns (see supplementary material Figure 21-26). Pyclone
4Pyclone was only applied to patients PD9694 and PD9849, since it needed estimated
major and minor allele copy numbers as input. This information was missing for the other
two patients.
PHYLOGENY-BASED TUMOR SUBCLONE IDENTIFICATION 21
reported significantly more clusters than the other two methods for patient
PD9694, but many clusters only had smaller than five mutations, which
might be due to overfitting noises. Moreover, SIFA’s estimates led to bet-
ter VAF fitting as shown in Figure 27 of the supplementary material. We
calculated a VAF matrix estimation from each posterior sample in all three
methods, computed its mean absolute difference to the observed VAF ma-
trix, and the distribution of the differences are presented as the boxes in the
figure. In all patients, SIFA has significantly lower VAF fitting error, indi-
cating that the incorporation of CNV information and phylogeny structure
can indeed improve model performance.
5. Discussion and Conclusion. In recent years, many studies have
shown that intra-tumor heterogeneity plays an important role in tumor
metastasis and treatment resistance. It is of great clinical importance to
correctly infer patients’ subclonal composition and phylogenetic structure.
For this purpose, we proposed SIFA, which is an extension of (Marass et al.,
2017) and (Lee et al., 2015) that enables simultaneous inference of subclone
SNV, CNV status and phylogenetic tree. SIFA achieved satisfactory results
in our simulation studies, and its application to four patients from a breast
cancer study also provided interesting insights.
In the Metropolis-Hastings sampling step of tree structures in SIFA, we
employed a novel tree proposal method which includes changing the tree
structure and the subclone fraction parameters at the same time. The method
successfully led to improved acceptance rate and better mixing efficiency. We
also provided proof that, under certain constraints, the proposed tree has
equivalent likelihood as the original one. Note that the constraints can also
serve as conditions for unidentifiability: if the underlying true fractions for
subclone D are indeed smaller than C in all samples (see Figure 3), then
the original tree and the proposed tree are indistinguishable in terms of like-
lihood. In this case, our method is able to produce both trees in posterior
samples, and the users can incorporate other prior information to decide
which tree structure is more likely to be true.
Our model runs one chain for each candidate K and uses the Bayes free
energy as the model selection criterion. BIC is used as model selection cri-
terion by some other methods. Although BIC is simpler in form, it requires
users to provide the number of free model parameters. Calculating this num-
ber is not trivial as we cannot simply count the number of parameters in
the model, when there are both continuous (F) and discrete (L,Z, T ) pa-
rameters that do not contribute equally to model complexity. Moreover, the
Bayes free energy criterion utilizes all posterior samples to assess model pre-
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dictive accuracy, which should give more comprehensive results compared
to criteria using pointwise estimates (such as AIC, BIC and DIC), which are
known to have issues when the posterior distributions have multiple modes.
In SIFA, we make several assumptions about the tumor evolution pro-
cess, which may limit the application in real data. For example, the infinite
sites assumption states that a locus can only be mutated once. While this
is true for most mutation loci in practice, users may encounter several loci
with multiple mutation types (e.g. A→ C and A→ G). Such cases indicate
violation of the infinite sites assumption, and we suggest users exclude such
mutation loci from the analysis. Second, when modeling the subclone frac-
tions parameter Θ, we assume the samples are independent, and therefore
can update Θ column by column. However, considering that the samples are
sometimes from the same tissue, dependence among samples may exist. Es-
pecially when the biopsy sites are close to each other, the subclone fractions
may appear to be similar as well. In such cases, modeling the dependency
among samples will likely provide improved inference of subclone fractions.
Third, SIFA is only suitable for analysis of WGS data. It may not be ap-
plicable to samples from other sequencing technologies, such as WES and
targeted deep sequencing, because the Poisson distribution assumption in
Equation 2.3 may not hold. Under such circumstances, other analysis tools
should be considered.
In all applications, we have used maximum number of mutated alleles
MS = 2 and maximum copy number MC = 4. The choices of the two
numbers may seem low for modeling extreme cases where loci acquire many
copies of mutated alleles or are subject to strong CNV, but it should be
flexible enough to model most mutation loci. Since the subclone inference
is dependent on mutation clusters, if most loci are correctly modeled, the
inference results should be robust against a few extreme cases. To further
examine the model’s sensitivity against different choices of MS and MC ,
we fit SIFA on the real dataset with MS = 3 and MC = 6. The resulting
estimation for Z and L were similar to the results reported in Section 4,
other than a few loci that were estimated to have larger numbers of mutated
copies or total copies. Inference for the subclone phylogeny also remained
the same for three of the four patients, except for patient PD9771 where the
new tree had a (0, 1, 2, 2) structure. However, this tree was also present in
the posterior samples from previous analysis as a minority tree.
Theoretically, SIFA can handle sampling for models with any K. However
in practice, the sampler becomes more time consuming as K gets larger. It
can take an unnecessarily long time if a large range of K’s is used. It is sug-
gested that users explore smaller ranges first and check the model selection
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metric. If the metric suggests the possibility of larger number of subclones,
for example when you see the metric keeps decreasing as K increases, then
it is necessary to explore a few more values for K.
Another limitation of SIFA is that users need to run the model for each
K in the pre-specified range. It may be preferable to spend less time on less
likely Ks. One possible future direction is to enable the sampler to jump
between models with different Ks, for example reconstructing the model
with a non-parametric prior for K. This modification is likely to increase
sampling efficiency, and at the same time bypass the need of model selection.
Source code and instructions for implementation of SIFA can be accessed
from https://github.com/zengliX/SIFApackage.
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APPENDIX A: SEGMENTATION METHOD
For genome segmentation, we use the multipcf function in R package
copynumber developed by Nilsen et al. (2012). It is a penalized regression
model with penalty placed on the number of segments. Suppose we ob-
serve normalized copy number measurements yi = (y
i
1, y
i
2, . . . , y
i
n) for the
ith sample, where i = 1, 2, . . . , T . Let S = {I1, I2, . . . , Im} be a genome
segmentation, where each Ik contains indices of loci in the kth segment. In
each segment, the loci are supposed to take the same copy number value,
thus multipcf minimizes the following loss function over S:
L(S|y1,y2, . . . ,yT, γ) =
T∑
i=1
∑
I∈S
∑
k∈I
(yik − y¯ iI )2 + γ|S|
where y¯ iI is the mean copy number of probes in segment I of sample i, |S|
is the number of segments, and γ is a penalty parameter. Larger values of γ
indicate a larger penalty for opening a new segment. In our implementation,
we select the optimal γ using BIC.
APPENDIX B: TREE REPRESENTATION PROOF
In this section, we will prove that any tree of size K can be represented as
a K-vector satisfying the constraints in Section 2.2.3, and any such vector
corresponds to a tree.
We focus on cases when K ≥ 2.
Given any tree, we sort the nodes in decreasing order of their heights, and
index them by 1, 2, . . . ,K. We then create the vector T by assigning Tk to
be the index of node k’s parent. Apparently index 1 refers to the root node,
thus T1 = 0. And for any node k ≥ 2, its parent must have greater height,
thus Tk ∈ {1, 2, . . . , k − 1} holds true.
Given any K-vector T satisfying the constraints, we let the first entry be
root node, and add an edge between nodes i, k if Tk = i. Apparently any
node k ≥ 2 has a path to the root, which impies the graph is connected.
The graph also has only K − 1 edges, thus it must be a tree.
APPENDIX C: EQUIVALENT TREE PROPOSAL PROOF
In this section, we prove that, under the condition that θqt ≥ θkt for all t,
the new tree proposed in our Metropolis-Hastings sampling step yields the
same likelihood as the original tree structure.
It is easy to check that the proposed Θ∗ leads to the following changes in
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the fraction matrix F:
f∗pt = fpt + fkt
f∗qt = fqt − fkt ∧ fqt(C.1)
f∗kt = fkt ∧ fqt (for all t = 1, 2, . . . , T )(C.2)
Figure 9 illustrates the tree structures before (left panel) and after (right
panel) rewiring subclone k to subclone q. To prove both tree structures
yield the same likelihood, we need to show that the theoretical VAF pjt =∑
k zjkfkt/
∑
k ljkfkt stays the same for every locus. It suffices to prove that
for every SNV and CNV, its cellularity does not change in the new tree.
Since the proposal only directly affects subclones k, p and q, we can focus
our proof just in these three subclones.
When the condition θqt ≥ θkt holds, fkt∧fqt becomes fkt. Thus equations
C.1 and C.2 can be simplified to f∗qt = fqt − fkt and f∗kt = fkt.
- For any SNV or CNV gk in subclone k, it has cellularity fkt in both
trees.
- For any gp in subclone p, it has original cellularity fpt+fkt+cp, where
cp is the sum fraction of p’s other descendant sucblones. In the new
tree, the value becomes f∗pt + cp = fpt + fkt + cp, thus the invariance
holds.
- For any gq in subclone q, its original cellularity is fqt + cq. And cellu-
larity in the new tree is f∗qt + f∗kt + cq = fqt + cq , where cq is similarly
defined as cp. Cellularity invariance also holds true.
. . .
gp; fpt gq; fqt
gk; fkt
=⇒
. . .
gp; f
∗
pt gq; f
∗
qt
gk; f
∗
kt
original tree proposed tree
Fig 9: Left panel: original tree; right panel: proposed tree
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APPENDIX D: SLICE SAMPLING
The method of slice sampling is commonly used to sample distributions
with bounded domain. It enables the sampler to jump between different local
modes even if they are far from each other, thus avoiding getting biased
samples.
Suppose our goal is to sample z from distrbution f(z) = Cg(z) and we
only know g(z), which is usually the case in Bayesian models. We intro-
duce a nuisance random variable u|z ∼ Unif(0, g(z)), then u, z have joint
distribution
p(z, u) = C1{u≤g(z)}
We intend to get samples of f(z) by sampling from the joint distribution
p(z, u) using Gibbs Sampling. In each iteration, we
1. Sample u∗ ∼ Unif(0, g(z))
2. Sample z∗ ∼ p(z|u∗) ∝ 1{g(z)≥u∗}, which is uniform on area {z : g(z) ≥
u∗}. Therefore, we can randomly propose z∗ from its support and
accept proposal if g(z∗) ≥ u∗
One practical issue in computation is that g(z) is usually near 0 when the
sample size is large, which makes it infeasible to sample from Unif(0, g(z))
. However, this can be fixed by working on the log scale. Let η = − log(u),
then η has a shifted Exponential distribution: Exp(1) − log g(z), which is
much easier to sample from.
Therefore, in the actual implementation of slice sampling, we use the
following more practical procedure in each iteration:
1. Sample η∗ ∼ Exp(1)− log g(z)
2. Randomly propose z∗ from its support and accept proposal if log g(z∗) ≥
−η∗
APPENDIX E: DERIVATIONS OF THE FULL CONDITIONED
DISTRIBUTIONS
• Posterior distribution of pi
Posterior distribution for pi is (with prior Beta(api, bpi)):
p(pi|Lo) ∝ p(Lo|pi)p(pi)
∝ pin(1− pi)S−np(pi)
∝ Beta(n+ api, S − n+ bpi)
where S is the number of genome segments and n is the number of segments
without CNV.
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• Posterior distribution of Θ
Since samples are independent, we can update Θ by columns.
p(Θt|D,X,Φ,Ω−Θt) = p(Θt|φt, Dt,Lo,Zo, T )
∝ p(Dt|φt,Θt,L)p(Xt|Dt,Z,L,Θt)p(Θt)
∝
∏
j
(Z′(j)Θt)
xjt [(L(j) − Z(j))′Θt]djt−xjte−
φt
2Gt
L′
(j)
Θtp(Θt)
where Gt =
∑
k θkt.
• Posterior distribution of Zo
Zo is sampled row by row:
p(Zo(j)|D,X,Φ,Ω−Zo(j)) = p(Zo(j)|X,D,Θ,Lo, T )
∝ p(Zo(j))
∏
t
p(xjt|djt, pjt)
∝ p(Zo(j))
∏
t
p
xjt
jt (1− pjt)djt−xjt
∝ p(Zo(j))
∏
t
(Z′(j)Ft)
xjt(L′(j)Ft − Z′(j)Ft)djt−xjt
• Posterior distribution of Lo
Rows of Lo in the same segment are sampled together. Consider loci in
segment ∆i, and assume they share the same CNV status L
o
(∆i):
p(Lo(∆i)|D,X, Φ ,Ω−Lo(j:j∈∆i)) = p(L
o
(∆i)|D,X,Φ,Θ,Zo, T )
∝ p(Lo(∆i))
∏
j∈∆i
∏
t
p(djt|φt,Ft,Lo(j) = Lo(∆i), T )×∏
j∈∆i
∏
t
p(xjt|djt,Ft,Zo(j),Lo(j) = Lo(∆i), T )
∝ p(Lo(∆i))
∏
j∈∆i
∏
t
[(L(∆i) − Z(j))
′
Ft]
djt−xjte−
φt
2
L
′
(∆i)
Ft
where L(∆i) is the length-K subclone copy number vector corresponding
to Lo(∆i) when tree structure is T .
• Posterior distribution of T
p(T |D,X,Φ,Ω−T ) = p(T |D,X,Φ,Lo,Zo,Θ)
∝ p(T )
∏
j,t
p(djt|φt,Θt,Lo, T )p(xjt|djt,Θt,Lo,Zo, T )
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APPENDIX F: SIMULATION ANALYSIS
F.1. Simulation true parameters. Details of the simulation param-
eters are presented in Figure 10.
F.2. Parameter specifications for Bayesian sampling. Model pa-
rameter specifications are presented in Table 2. Markov chain sampling pa-
rameters are presented in Table 3.
Table 2
Prior distribution parameters used in the applications of SIFA to simulations
Parameters value
number of samples (T ) 4
number of loci (J) 200
maximum possible mutant copy (MS) 2
maximum possible total copy (MC) 4
Θ Dirichlet prior parameter (γ) 1.5
pi Beta prior parameter ( api, bpi ) (10000,1)
Zo prior parameter (ζ) 10
Table 3
MCMC sampling parameters used in the applications of SIFA to simulations
Parameters value
Number of chains 8
Temperature increment (∆T ) 0.35
posterior sample size 4000
burn-in samples size 4000
sample size for adaptive parameter tuning 2000
interval to perform chain swap 30
probability to perform tree slice sampling 0.15
probability to perform tree Metropolis-Hastings sampling 0.85
F.3. Simulation results on different tree structures. Results are
presented in Figure 11.
APPENDIX G: REAL DATA ANALYSIS
G.1. Data quality control. There were more than 3000 ∼ SNV loci
in the raw data for different patients, and many of them were present due
to sequencing noises. To screen out loci that were less useful for our analysis
and reduce input sample size, we went through the following process:
1. Removed loci with total reads ≤ 15 in any samples
2. Calculated observed VAF, and removed loci with average VAF ≤ 0.1
PHYLOGENY-BASED TUMOR SUBCLONE IDENTIFICATION 29
tree structure
●
● ●
1
2 3
0
50
100
150
200
1 2 3
subclone id
loc
i
0.00
0.25
0.50
0.75
1.00
value
SNV matrix: Z
0
50
100
150
200
1 2 3
subclone id
loc
i
0
1
2
3
4
value
CNV matrix: L
0.00
0.25
0.50
0.75
1.00
sample 1 sample 2 sample 3 sample 4
sample
fra
cti
on
subclone
1
2
3
Subclone fractions
0.0
0.1
0.2
0.3
0.4
0.5
sample1 sample2 sample3 sample4
sample
VA
F
group
2
3
Observed VAF by mutation group
tree structure
●
●
● ●
1
2
3 4
0
50
100
150
200
1 2 3 4
subclone id
loc
i
0.00
0.25
0.50
0.75
1.00
value
SNV matrix: Z
0
50
100
150
200
1 2 3 4
subclone id
loc
i
0
1
2
3
4
value
CNV matrix: L
0.00
0.25
0.50
0.75
1.00
sample 1 sample 2 sample 3 sample 4
sample
fra
cti
on
subclone
1
2
3
4
Subclone fractions
0.0
0.2
0.4
0.6
0.8
sample1 sample2 sample3 sample4
sample
VA
F
group
2
3
4
Observed VAF by mutation group
tree structure
●
● ●
● ●
1
2 3
4 5
0
50
100
150
200
1 2 3 4 5
subclone id
loc
i
0.00
0.25
0.50
0.75
1.00
value
SNV matrix: Z
0
50
100
150
200
1 2 3 4 5
subclone id
loc
i
0
1
2
3
4
value
CNV matrix: L
0.00
0.25
0.50
0.75
1.00
sample 1 sample 2 sample 3 sample 4
sample
fra
cti
on
subclone
1
2
3
4
5
Subclone fractions
0.00
0.25
0.50
0.75
sample1 sample2 sample3 sample4
sample
VA
F
group
2
3
4
5
Observed VAF by mutation group
tree structure
●
●
● ●
●
1
2
3 4
5
0
50
100
150
200
1 2 3 4 5
subclone id
loc
i
0.00
0.25
0.50
0.75
1.00
value
SNV matrix: Z
0
50
100
150
200
1 2 3 4 5
subclone id
loc
i
0
1
2
3
4
value
CNV matrix: L
0.00
0.25
0.50
0.75
1.00
sample 1 sample 2 sample 3 sample 4
sample
fra
cti
on
subclone
1
2
3
4
5
Subclone fractions
0.0
0.2
0.4
0.6
0.8
sample1 sample2 sample3 sample4
sample
VA
F
group
2
3
4
5
Observed VAF by mutation group
tree structure
●
●
●
●
●
1
2
3
4
5
0
50
100
150
200
1 2 3 4 5
subclone id
loc
i
0.00
0.25
0.50
0.75
1.00
value
SNV matrix: Z
0
50
100
150
200
1 2 3 4 5
subclone id
loc
i
0
1
2
3
4
value
CNV matrix: L
0.00
0.25
0.50
0.75
1.00
sample 1 sample 2 sample 3 sample 4
sample
fra
cti
on
subclone
1
2
3
4
5
Subclone fractions
0.00
0.25
0.50
0.75
1.00
sample1 sample2 sample3 sample4
sample
VA
F
group
2
3
4
5
Observed VAF by mutation group
Fig 10: The underlying truth for simulations. The first two rows display
simulation parameters for K = 3, 4, and the last three rows for K = 5. The
second column is SNV matrix, where the red blocks represent one mutant
copy gain. The third column is CNV matrix, where the green blocks rep-
resent one copy loss, the red blocks indicate one copy gain, and the black
blocks are copy neutral. The fourth column depicts subclone fraction fluc-
tuations across samples, where the vertical lengths of the colored segments
represent subclones’ fractions. The fifth column is the observed VAF (one
line for each locus) generated from corresponding parameters in each row
(at sequencing depth 40). Mutations originated from different subclones are
coded with different colors.
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Fig 11: Simulation results under scenario K = 5,depth = 40 and different
tree structures.
3. Performed K-means clustering using loci’s VAF with specified number
of clusters = 60. In each cluster, the loci had highly similar VAF pat-
terns, thus we randomly removed half of the loci to reduce redundant
information
G.2. Sampling parameters. Model parameter specifications for real
data analysis are presented in Table 4. Markov chain sampling parameters
are presented in Table 5.
Table 4
Prior distribution parameters used in the applications of SIFA to the breast cancer
dataset
Parameters value
number of samples (T ) 4
number of loci (J) 200
maximum possible mutant copy (MS) 2
maximum possible total copy (MC) 4
Θ Dirichlet prior parameter (γ) 1.5
pi Beta prior parameter ( api, bpi ) (10000,1)
Zo prior parameter (ζ) 0.01
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APPENDIX H: CALCULATION OF POINT ESTIMATES
It is not trivial to obtain posterior point estimates, because under different
tree structures the parameters Z,L, and F have different interpretations. In
this section, we describe in detail how the point estimates are calculated.
Note that one phylogenetic tree may have different representations. For
example, if a tree has two leaf subclones with the same parent, we can switch
them in the tree and their corresponding columns/rows in Z,L, and F, and
yield an equivalent representation of the tree. To unify posterior samples
with different tree parameters that may refer to the same tree, we employ
the following procedure to process each posterior sample:
1. Let T ,Z be the tree and SNV matrix estimate in the current sample,
and similarly define Tprev,Zprev for its previous sample;
2. If T 6= Tprev, we list all permutations (of columns) of Z and identify the
permutation σ that minimizes the average absolute difference between
Z and Zprev;
3. Reindex T by permutation σ. If the resulting new tree is valid (satisfies
the constraints specified in Section 2.2.3), we also change Z, L, and F
according to σ. Otherwise we make no change to this sample.
After the above postprocessing, we typically end up with a single tree
structure. Then we use median Z,L, and mean F as point estimates. How-
ever, it is possible to have more than one tree in the posterior samples. It is
not reasonable to combine samples from essentially different trees to calcu-
late point estimates. In such cases, we report the point estimates from the
majority tree, but it is also suggested to examine all the tree structures in
the samples.
Table 5
MCMC sampling parameters used in the applications of SIFA to the breast cancer dataset
Parameters value
Number of chains 8
Temperature increment (∆T ) 0.35
posterior sample size 4000
burn-in samples size 4000
sample size for adaptive parameter tuning 2000
interval to perform chain swap 30
probability to perform tree slice sampling 0.15
probability to perform tree the Metropolis-Hastings sampling 0.85
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